Insider Transactions in Q4 2022 at Immuneering Corp (IMRX)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2022
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.11%
|
$7,500
$3.01 P/Share
|